Insulin and Cancer, Boyd, Integr. Cancer. Ther., 2003; 2 (4): 315-329.
Insulin-like Growth Factor 1 Tied to Prostate
Cancer Risk,
Insulin-Like Growth Factor I Receptor Promotes Gastric Cancer Adachi. et al.,Gut 2005; 54: 591-600.
Diabetes, High Glucose Levels Linked to Cancer in Korean Study, Jee, et al., JAMA 2005; 194-202
and editorial p. 235-236.
Diabetes Triples Risk of Liver Cancer, El-Serag, et al, Gut, 2005; 54: 533-539.
Elevated IGF-1
Linked to Raised Risk of Cancer in Premenopausal Women, Shi, et al, Int. J. Cancer 2004; 111: 418-423.
High Dietary Glycemic
Load May Increase Colorectal Cancer Risk in Women, Higginbotham, et al, J. Natl. Cancer Inst. 2004; 96: 229-233.
High Dietary
Glycemic Load and Insulin Resistance Combine to Increase Pancreatic Cancer Risk, Michaud, et al., J. Natl. Cancer Inst.2002; 94: 1293-1300.
Controlling Hyperglycemia as an Adjunct to Cancer Therapy, Krone & Ely, Integr. Cancer Ther. 2005;
4 (1): 25-31.
Fasting insulin and outcome in early-stage breast cancer- results of a prospective cohort study, Goodwin,
et al, J. Clin. Oncol., 2002; 20: 42-51.
Glycemic Index, Glycemic Load and Thyroid Cancer Risk, Randi, Ferraroni, Talamini,
et al., Annals of Oncol. 2008; 192: 380-383.
Green Tea Polyphenols Inhibit IGF-1 Signalling in Prostate Cancer Model, Mukhtar,
et al., Cancer Res. 2004; 64: 8715-8722.
Postprandial Hyperinsulinemia Accelerates Growth of Hepatocellular Carcinoma,Kawata, et al., Gut 2002; 51: 100-104.
Insulin-like Growth Factor -1 Activates Gene Transcription Programs Strongly Associated
with Poor Breast Cancer Prognosis, Chreighton, Casa, Lazard, et al., J Clin Oncol 2008; 26 (25): 4078-4085.
Insulin,
Insulin-like Growth Factors and
2001; 131 (Suppl. 11): s3109-3120.
Glycemic
Index, Glycemic Load, and Cancer Risk: A Meta-analysis, Gnagnarella, Gandini, La Vecchia, & Maisonneuve, Amer. J. Clin.
Nutr. 2008; 87 (6): 1793-1801.
Up-regulation of IGF Binding Protein-1 as an Anti-carcinogenic Strategy: Relevance to Caloric
Restriction, Exercise, and Insulin Sensitivity, McCarty, Medical Hypotheses 1997; 48 (4): 297-308.
The Insulin-like Growth Factor
System as a Treatment Target in Breast Cancer, Yee, Sem. Oncol. 2002; 29 (3 Suppl 11): 86-95.
Cross-talk Among Estrogen
Receptor, Epidermal Growth Factor, and Insulin-like Growth Factor Signaling in Breast Cancer, Lee, Cui & Oesterreich, Clin. Cancer
Res. 2001; 7 (12 Suppl): 4429s-4435s.
Tyrosine Kinase Signalling in Breast Cancer: Insulin-like Growth Factors and Their Receptors
in Breast Cancer, Zhang & Yee, Breast Cancer Res. 2000; 2 (3): 170-175.
Insulin-like Growth Factors and Cancer, Furstenberger
& Senn, Lancet Oncol. 2002; 3 (5): 298-302.
Insulin-Like Growth Factor (IGF) Family and Prostate Cancer, Gennigens, Menetrier-Caux
& Droz, Crit. Rev. Oncol. Hematol. 2006; 58 (2): 124-145.
Activation of Estrogen Receptor-mediated Gene Transcription
by IGF-I in Human Breast Cancer Cells, Lee, Weng, Jackson & Yee, J. Endocrinol. 1997; 152 (1): 39-47.
Vitamin D Analogue
EB1089-induced Prostate Regression is Associated with Increased Gene Expression of Insulin-like Growth Factor Binding Proteins, Nickerson
T. Huynh H. J. Endocrinol. 1999; 160 (2): 223-229.
Pharmacological Modulation of IGF Serum Concentrations as a Therapeutic
Approach to Control the Growth of Malignant Breast Tumors, Singer, Hudelist, Schreiber & Kubista, Drugs Today (Barc). 2003; 39
(2): 115-125.
Inhibition of Insulin-like Growth Factor I Receptor Signaling by the Vitamin D Analogue EB1089 in MCF-7 Breast
Cancer Cells: A Role for Insulin-like Growth Factor Binding Proteins, Rozen & Pollak, Int. J. Oncol. 1999; 15 (3):
589-594.
Insulin, Insulin-like Growth Factors, Insulin Resistance, and Neoplasia, Pollack MN. Am. J. Clin. Nutr. 2007;
86 (3): s820-822.